Abstract
BACKGROUND: Schizophrenia is a highly heritable disorder characterized by increased cortical thinning throughout the life span. Studies have reported a shared genetic basis between schizophrenia and cortical thickness. However, no genes whose expression is related to abnormal cortical thinning in schizophrenia have been identified.
METHODS: We conducted linear mixed models to estimate the rates of accelerated cortical thinning across 68 regions from the Desikan-Killiany atlas in individuals with schizophrenia compared with healthy control participants from a large longitudinal sample (ncases = 169 and ncontrols = 298, ages 16-70 years). We studied the correlation between gene expression data from the Allen Human Brain Atlas and accelerated thinning estimates across cortical regions. Finally, we explored the functional and genetic underpinnings of the genes that contribute most to accelerated thinning.
RESULTS: We found a global pattern of accelerated cortical thinning in individuals with schizophrenia compared with healthy control participants. Genes underexpressed in cortical regions that exhibit this accelerated thinning were downregulated in several psychiatric disorders and were enriched for both common and rare disrupting variation for schizophrenia and neurodevelopmental disorders. In contrast, none of these enrichments were observed for baseline cross-sectional cortical thickness differences.
CONCLUSIONS: Our findings suggest that accelerated cortical thinning, rather than cortical thickness alone, serves as an informative phenotype for neurodevelopmental disruptions in schizophrenia. We highlight the genetic and transcriptomic correlates of this accelerated cortical thinning, emphasizing the need for future longitudinal studies to elucidate the role of genetic variation and the temporal-spatial dynamics of gene expression in brain development and aging in schizophrenia.
Original language | English |
---|---|
Pages (from-to) | 376-389 |
Number of pages | 14 |
Journal | Biological Psychiatry |
Volume | 96 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Sept 2024 |
Externally published | Yes |
Bibliographical note
Copyright © 2024 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.Funding
This work was supported by the Spanish Ministry of Science, Innovation and Universities. Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI17/00997, PI19/01024, PI20/00721), co-financed by ERDF Funds from the European Commission, \u201CA way of making Europe\u201D, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds. European Union Seventh Framework Program under grant agreements FP7-4-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN), and FP7- HEALTH-2013-2.2.1-2-602478 (Project METSY); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS), Fundaci\u00F3n Familia Alonso, Fundaci\u00F3n Alicia Koplowitz, and Fundaci\u00F3n Mutua Madrile\u00F1a. CM D\u00EDaz-Caneja holds a Juan Rod\u00E9s Grant from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (JR19/00024). J.G-P holded a Sara Borrell Grant during the development of the research from Instituto de Salud Carlos III (CD20/00118).
Funders | Funder number |
---|---|
Ministry of Science, Innovation and Universities | JR19/00024 |
Instituto de Salud Carlos III | SAM16PE07CP1, PI16/02012, PI17/00997, PI19/01024, PI20/00721, CD20/00118 |
European Commission | |
(Centro de Investigación Biomédica en Red de Salud Menta | |
Madrid Regional Government | B2017/BMD-3740 AGES-CM-2 |
European Union Seventh Framework Program | FP7-4-HEALTH-2009-2.2.1-2-241909, FP7- HEALTH-2013-2.2.1-2-603196, FP7- HEALTH-2013-2.2.1-2-602478 |
Innovative Medicines Initiatives | 115916, Project PRISM, 777394, Project AIMS-2-TRIALS |
Fundación Familia Alonso | |
Fundación Alicia Koplowitz | |
Fundación Mutua Madrileña |
Keywords
- Brain imaging
- Cortical thinning
- Genetics
- Schizophrenia
- Transcriptomics